Two engagement tracks for fractional-order population pharmacokinetic analysis. Choose the one that fits your role.
Free retrospective fractional PK analysis of published datasets in exchange for co-authorship on the resulting publication. Priority areas: oncology, narrow-therapeutic-index drugs, pediatric PK, compounds with documented anomalous kinetics.
Academic collaboration →Fractional-order population PK analysis of proprietary or clinical-stage compounds, under NDA and GDPR-compliant processing.
Industry pilot →